Surya Center Treatment Facility Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-05-2024
- Paid Up Capital ₹ 0.10 M
as on 15-05-2024
- Company Age 2 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 M
as on 15-05-2024
About Surya Center Treatment Facility
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.00 M.
Meghana Kore and Prutha Edwankar serve as directors at the Company.
- CIN/LLPIN
U90000PN2022PTC217159
- Company No.
217159
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Dec 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Surya Center Treatment Facility?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Prutha Edwankar | Director | 21-Dec-2022 | Current |
Meghana Kore | Director | 21-Dec-2022 | Current |
Financial Performance of Surya Center Treatment Facility.
Enhance accessibility to Surya Center Treatment Facility's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Surya Center Treatment Facility?
Unlock access to Surya Center Treatment Facility's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Sury Center Treatment Facility Management Private LimitedActive 6 years 24 days
Meghana Kore and Prutha Edwankar are mutual person
- Wisefinch Robotics And Automation Private LimitedActive 3 years 4 months
Prutha Edwankar is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Yes Bank Limited Creation Date: 27 Nov 2023 | ₹5.00 M | Open |
How Many Employees Work at Surya Center Treatment Facility?
Unlock and access historical data on people associated with Surya Center Treatment Facility, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surya Center Treatment Facility, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Center Treatment Facility's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.